Piper Sandler Downgrades Horizon Therapeutics (HZNP) to Neutral Pending Takeover
Tweet Send to a Friend
Piper Sandler analyst David Amsellem downgraded Horizon Therapeutics (NASDAQ: HZNP) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
